Sinotherapeutics Inc. A (688247) — Net Asset Quality Index
Sinotherapeutics Inc. A (688247) has a Net Asset Quality Index of 90.0% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥1.45 Billion minus total liabilities of CN¥145.56 Million yields net assets of CN¥1.31 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read Sinotherapeutics Inc. A (688247) financial obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Sinotherapeutics Inc. A Net Asset Quality Index Over Time (2020–2025)
This chart shows how Sinotherapeutics Inc. A's Net Asset Quality Index has evolved across 6 annual periods from 2020 to 2025. As of March 2026, the index stands at 90.0%, representing net assets of CN¥1.31 Billion against total assets of CN¥1.45 Billion CNY. For live market cap and overall valuation, see Sinotherapeutics Inc. A (688247) market capitalisation.
Annual Net Asset Quality Index for Sinotherapeutics Inc. A (2020–2025)
The table below presents the year-by-year Net Asset Quality Index for Sinotherapeutics Inc. A from 2020 to 2025, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See what is Sinotherapeutics Inc. A's book value for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 89.8% | CN¥1.29 Billion | CN¥1.44 Billion | CN¥146.12 Million | ▲ +2.2 pp |
| 2024 | 87.6% | CN¥1.27 Billion | CN¥1.45 Billion | CN¥180.30 Million | ▼ -1.3 pp |
| 2023 | 88.9% | CN¥1.21 Billion | CN¥1.36 Billion | CN¥151.36 Million | ▲ +0.5 pp |
| 2022 | 88.4% | CN¥1.18 Billion | CN¥1.33 Billion | CN¥155.05 Million | ▲ +6.9 pp |
| 2021 | 81.4% | CN¥705.19 Million | CN¥865.81 Million | CN¥160.62 Million | ▲ +5.8 pp |
| 2020 | 75.7% | CN¥562.38 Million | CN¥743.14 Million | CN¥180.76 Million | — |